Expect Less Focus on Psychiatric Effects With Varenicline

February 2017

Boxed warnings about psychiatric events will be REMOVED from varenicline (Chantix) and bupropion labeling for smoking cessation.

These warnings about mood changes, agitation, nightmares, and other psychiatric risks were originally added based on case reports.

Now a large trial suggests that these meds do NOT increase psychiatric side effects in patients quitting smoking.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote